Urologia Internationalis

Original Paper

Sixteen Years of Experience with Stone Management in Horseshoe Kidneys

Viola D. · Anagnostou T. · Thompson T.J. · Smith G. · Moussa S.A. · Tolley D.A.

Author affiliations

The Scottish Lithotriptor Centre, Western General Hospital, Edinburgh, UK

Related Articles for ""

Urol Int 2007;78:214–218

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: November 14, 2005
Accepted: September 26, 2006
Published online: April 04, 2007
Issue release date: April 2007

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 4

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Introduction: Horseshoe kidney is the commonest congenital renal fusion anomaly, and is often complicated by urolithiasis. We focus on our 16 years of experience with stone management in horseshoe kidneys. Materials and Methods: We reviewed the progress of 44 patients treated between 1987 and 2002. Shock wave lithotripsy (SWL) was used in 25 patients; the average stone surface area was 91 (range 10–1,600) mm2 and average follow-up was 36.5 (range 1–91) months. 19 patients underwent percutaneous nephrolithotomy (PCNL); the average stone surface area was 197 (range 6–2,400) mm2. Follow-up data are available for 8 patients and the average follow-up was 42.3 (range 3–144) months. Results: In the SWL group the 3-month stone-free rate (SFR) was only 31%. In the PCNL group the SFR was 75% on the postoperative day-1 KUB. Complications occurred in 9 patients. Conclusions: Stone management in horseshoe kidneys is challenging: PCNL produces a higher SFR with minimal major complications and failed access. PCNL thus appears to be the preferred management option in patients with urolithiasis in horseshoe kidneys.

© 2007 S. Karger AG, Basel




Related Articles:


References

  1. Bauer S: Anomalies of the Upper Urinary Tract. Horseshoe Kidney in Campbell’s Urology, ed 8. Philadelphia, Saunders, 2002, vol 3, pp 1903–1906.
  2. Morgagnus IB: De sedibus et causis morborum per anatomen indagatis. Venetiis: Ex tipographia Remondiniana, liber 3, epist. 48, 1761, art. 16, p 233.
  3. Yohannes P, Smith AD: The endourological management of complications associated with horseshoe kidney. J Urol 2002;168:5–8.
  4. Al-Otabi K, Hosking DH: Percutaneous stone removal in horseshoe kidneys. J Urol 1999;162:674–677.
  5. Raj GV, Auge BK, Weizer AZ, et al: Percutaneous management of calculi within horseshoe kidneys. J Urol 2003;170:48–51.
  6. Jones DJ, Wickham JEA, Kellett MJ: Percutaneous nephrolithotomy for calculi in horseshoe kidneys. J Urol 1991;145:481–483.
  7. Lampel A, Hohenfellner M, Schultz-Lampel D, et al: Urolithiasis in horseshoe kidneys: therapeutic management. Urology 1996;47:182–186.
  8. Lingerman JE, Saw KC: Percutaneous operative procedures in horseshoe kidneys (abstract 1436). J Urol 1999;161(suppl):371.
    External Resources
  9. Peartree RJ, Ruotolo RA, Khuri FJ, et al: Percutaneous stone removal in horseshoe kidney. Urology 1986;28:41–43.
  10. Salas M, Gelet A, Martin X, et al: Horseshoe kidney: the impact of percutaneous surgery. Eur Urol 1992;21:134–137.
  11. Ryan MJ, Murphy BL, Lee MJ, et al: Percutaneous ultrasonic lithotripsy in a patient with horseshoe kidney. Am J Roentgenol 1997;169:447–451.
  12. Collado Serra A, Ruben Parada M, Férran Rousand B, et al: Current management of calculi in horseshoe kidneys. Scand J Urol Nephrol 2000;34:114–118.
  13. Esuvaranatha K, Tan EC, Tung KH, et al: Stones in horseshoe kidneys. J Urol 1991;146:1213–1215.
    External Resources
  14. Blasco Caseres FJ, Ibarz Servio L, Ramon Dalmau M, et al: Extracorporeal shock-wave lithotripsy in horseshoe kidney. Actas Urol Esp 1994;18(suppl):417–423.
    External Resources
  15. Fletcher EW, Kettlewell MG: Antegrade pyelography in a horseshoe kidney. Am J Roentgenol Radium Ther Nucl Med 1973;119:720–722.
  16. Segura JW, Patterson DE, Leroy AJ, et al: Percutaneous removal of kidney stones: review of 1,000 cases. J Urol 1985;134:1077–1081.
  17. Jones DJ, Russell GL, Kellett MJ, et al: The changing practice of percutaneous stone surgery. Review of 1000 cases 1981–1988. Br J Urol 1990;66:1–5.
  18. Clayman RV, Surya V, Miller RP, et al: Percutaneous nephrolithotomy: extraction of renal and ureteral calculi from 100 patients. J Urol 1984;131:868–871.
  19. Janestschek G, Kunzel H: Percutaneous nephrolithotomy in horseshoe kidneys. Br J Urol 1988;62:117–122.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: November 14, 2005
Accepted: September 26, 2006
Published online: April 04, 2007
Issue release date: April 2007

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 4

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP